← Back to Search

Behavioural Intervention

Fisher Wallace Cranial Electrotherapy Stimulator (Active Device) for Depression (CES-MDD Trial)

N/A
Waitlist Available
Led By Kyle Lapidus, MD, PhD
Research Sponsored by Fisher Wallace Laboratories
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change at week two compared to baseline.
Awards & highlights

CES-MDD Trial Summary

This trial will test if a device that sends electrical signals to the brain can help people with major depression.

Eligible Conditions
  • Depression

CES-MDD Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~four weeks following baseline.
This trial's timeline: 3 weeks for screening, Varies for treatment, and four weeks following baseline. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in the Beck Depression Inventory Second Edition (BDI-II) at Week Two Compared to Baseline.
Secondary outcome measures
Beck Depression Inventory Second Edition (BDI-II) Responder Rate by Time Point (% of Subjects With a 50% or Better Improvement in Score From Baseline).
Change in the Beck Depression Inventory Second Edition (BDI-II) at Weeks One and Four Compared to Baseline.
Change in the Patient Health Questionnaire-9 (PHQ-9) at Weeks One, Two, and Four Compared to Baseline.
+1 more

CES-MDD Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Fisher Wallace Cranial Electrotherapy Stimulator (Active Device)Active Control1 Intervention
The Fisher Wallace Stimulator provides cranial electrotherapy stimulation and is an active device.
Group II: Fisher Wallace Cranial Electrotherapy Stimulator (Placebo Device)Placebo Group1 Intervention
The placebo device is designed to provide exactly the same patient experience as the active device; however, the placebo device will not deliver the same frequencies as the active device. The placebo device will provide no therapeutic benefit.

Find a Location

Who is running the clinical trial?

Climb Technologies, Inc.Industry Sponsor
Fisher Wallace LaboratoriesLead Sponsor
1 Previous Clinical Trials
21 Total Patients Enrolled
NAMSAOTHER
45 Previous Clinical Trials
16,668 Total Patients Enrolled
1 Trials studying Depression
6,456 Patients Enrolled for Depression

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
New Jersey
How old are they?
18 - 65
What site did they apply to?
New York Neuromodulation Medical, PLLC
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
Cranial Electrotherapy Stimulation for the Treatment of Major Depressive Disorder in Adults
2022. "Cranial Electrotherapy Stimulation for the Treatment of Major Depressive Disorder in Adults". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05384041.
~87 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top